Renaissance Technologies’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
24,670
+2,300
| +10% | +$2.05K | ﹤0.01% | 3466 |
|
|
2025
Q1 | $11.6K | Buy |
22,370
+4,200
| +23% | +$2.18K | ﹤0.01% | 3387 |
|
|
2024
Q4 | $9.27K | Buy |
+18,170
| New | +$9.27K | ﹤0.01% | 3521 |
|
|
2024
Q3 | – | Sell |
-8,943
| Closed | -$70.8K | – | 3764 |
|
|
2024
Q2 | $70.8K | Buy |
8,943
+662
| +8% | +$5.24K | ﹤0.01% | 3243 |
|
|
2024
Q1 | $112K | Buy |
8,281
+848
| +11% | +$11.5K | ﹤0.01% | 3348 |
|
|
2023
Q4 | $80K | Buy |
7,433
+3,146
| +73% | +$33.9K | ﹤0.01% | 3359 |
|
|
2023
Q3 | $28K | Buy |
4,287
+1,365
| +47% | +$8.92K | ﹤0.01% | 3482 |
|
|
2023
Q2 | $53K | Sell |
2,922
-517
| -15% | -$9.38K | ﹤0.01% | 3605 |
|
|
2023
Q1 | $81K | Buy |
3,439
+1,017
| +42% | +$24K | ﹤0.01% | 3551 |
|
|
2022
Q4 | $61K | Buy |
2,422
+1,746
| +258% | +$44K | ﹤0.01% | 3761 |
|
|
2022
Q3 | $21K | Buy |
+676
| New | +$21K | ﹤0.01% | 3892 |
|
|
2021
Q3 | – | Sell |
-12,183
| Closed | -$472K | – | 3709 |
|
|
2021
Q2 | $472K | Buy |
12,183
+9,375
| +334% | +$363K | ﹤0.01% | 2985 |
|
|
2021
Q1 | $147K | Sell |
2,808
-21,575
| -88% | -$1.13M | ﹤0.01% | 3190 |
|
|
2020
Q4 | $1.66M | Buy |
+24,383
| New | +$1.66M | ﹤0.01% | 2233 |
|
|
2020
Q3 | – | Sell |
-5,340
| Closed | -$206K | – | 3568 |
|
|
2020
Q2 | $206K | Sell |
5,340
-15,146
| -74% | -$584K | ﹤0.01% | 3149 |
|
|
2020
Q1 | $615K | Buy |
20,486
+14,527
| +244% | +$436K | ﹤0.01% | 2657 |
|
|
2019
Q4 | $676K | Buy |
+5,959
| New | +$676K | ﹤0.01% | 2790 |
|
|
2019
Q2 | – | Sell |
-5,060
| Closed | -$276K | – | 3688 |
|
|
2019
Q1 | $276K | Buy |
+5,060
| New | +$276K | ﹤0.01% | 3120 |
|
|
2018
Q4 | – | Sell |
-2,698
| Closed | -$124K | – | 3524 |
|
|
2018
Q3 | $124K | Buy |
2,698
+2,064
| +326% | +$94.9K | ﹤0.01% | 3222 |
|
|
2018
Q2 | $14K | Buy |
+634
| New | +$14K | ﹤0.01% | 3222 |
|